ZyVersa Therapeutics (NASDAQ:ZVSA) Stock Quotes, Forecast and News Summary

Q: What sector and industry does ZyVersa Therapeutics (ZVSA) operate in?

ZyVersa Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

ZyVersa Therapeutics Stock (NASDAQ: ZVSA) stock price, news, charts, stock research, profile.

Open	$2.00
Close	$2.01
Volume / Avg.	11.26K / 143.84K
Day Range	$1.95 - $2.01
52 Wk Range	1.90 - 84.77
Market Cap	$2.13M
P/E Ratio	0.00
Dividend Yield	-
Exchange	NASDAQ
RSI	29
Short Interest	0.9%
Days to Cover	1

Recent News

Why Intel Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Avi Kapoor

What's Going On With ZyVersa Stock?

ZyVersa Therapeutics shares are trading higher Monday after the company announced the publication of a scientific paper in a peer-reviewed journal that reinforces the rationale for inhibiting ASC with IC 100 to potentially attenuate cardiac comorbidities in patients with Alzheimer's Disease.

Erica Kollmann

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$2.00
Close	$2.01
Volume / Avg.	11.26K / 143.84K
Day Range	$1.95 - $2.01
52 Wk Range	1.90 - 84.77
Market Cap	$2.13M
P/E Ratio	0.00
Dividend Yield	-
Exchange	NASDAQ
RSI	29
Short Interest	0.9%
Days to Cover	1

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy ZyVersa Therapeutics (ZVSA) stock?

You can purchase shares of ZyVersa Therapeutics (NASDAQ:ZVSA) through any online brokerage.

View our list of the best stock brokerages

Who are ZyVersa Therapeutics (ZVSA) competitors?

Other companies in ZyVersa Therapeutics’s space includes: Dermata Therapeutics (NASDAQ:DRMA), Entero Therapeutics (NASDAQ:ENTO), Bone Biologics (NASDAQ:BBLG), Qualigen Therapeutics (NASDAQ:QLGN) and Cyclacel Pharmaceuticals (NASDAQ:CYCC).

What is the forecast, or price target, for ZyVersa Therapeutics (ZVSA) stock?

ZyVersa Therapeutics has a consensus price target of $12.00.

What is the current price for ZyVersa Therapeutics (ZVSA)?

The stock price for ZyVersa Therapeutics (NASDAQ: ZVSA) is $2.1 last updated October 30, 2024 at 8:16 AM EDT.

Does ZyVersa Therapeutics (ZVSA) pay a dividend?

There are no upcoming dividends for ZyVersa Therapeutics.

When is ZyVersa Therapeutics (NASDAQ:ZVSA) reporting earnings?

ZyVersa Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.

Is ZyVersa Therapeutics (ZVSA) going to split?

There is no upcoming split for ZyVersa Therapeutics.

What sector and industry does ZyVersa Therapeutics (ZVSA) operate in?

ZyVersa Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

ZyVersa Therapeutics

ZyVersa Therapeutics (ZVSA) Forecast